-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Dyne Therapeutics, Raises Price Target to $60

Benzinga·12/08/2025 14:49:15
語音播報
HC Wainwright & Co. analyst Ananda Ghosh maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from $46 to $60.